Accuray Appoints New Chief Commercial Officer

Paul Miele to lead commercial strategy and sales growth for radiation therapy systems provider.

Apr. 6, 2026 at 2:13pm

Got story updates? Submit your updates here. ›

Accuray Incorporated, a leading provider of radiation therapy systems for cancer treatment, has announced the appointment of Paul Miele as their new Senior Vice President and Chief Commercial Officer. Miele brings extensive global commercial leadership experience and a proven track record of driving transformation and sales growth in the medical technology industry.

Why it matters

Accuray's radiation therapy systems are critical tools in the fight against cancer, and the company's ability to effectively market and sell these products is essential to expanding patient access to advanced cancer treatments. Miele's appointment signals Accuray's commitment to strengthening its commercial capabilities and driving growth in a competitive medical technology landscape.

The details

In his new role, Miele will be responsible for leading Accuray's global commercial strategy, sales operations, and go-to-market initiatives. He will oversee the company's sales, marketing, and customer service functions, with a focus on accelerating the adoption of Accuray's radiation therapy solutions worldwide.

  • Miele's appointment was announced on April 6, 2026.

The players

Accuray Incorporated

A leading provider of radiation therapy systems for cancer treatment, based in Madison, Wisconsin.

Paul Miele

The newly appointed Senior Vice President and Chief Commercial Officer at Accuray, bringing extensive global commercial leadership experience in the medical technology industry.

Got photos? Submit your photos here. ›

The takeaway

Accuray's appointment of Paul Miele as Chief Commercial Officer underscores the company's focus on strengthening its commercial capabilities and driving growth in the highly competitive medical technology sector, which is crucial for expanding patient access to its advanced radiation therapy solutions.